Evidence map›Paper›PMID 27239795›Full record

ArticleNature structural & molecular biology2016

Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.

Ruth M Densham, Alexander J Garvin, Helen R Stone, Joanna Strachan, Robert A Baldock, Manuel Daza-Martin, Alice Fletcher, Sarah Blair-Reid, James Beesley, Balraj Johal and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 288 citations in OpenAlex.

  1. Article
  2. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  3. TheBiomolecular NMR assignments · 2026
    Article
  4. TheBiomolecular NMR assignments · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?International journal of molecular sciences · 2025
    Review
  18. Article
  19. Review
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Ruth M DenshamBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Alexander J GarvinBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Helen R StoneBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Joanna StrachanBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Robert A BaldockGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.
Manuel Daza-MartinBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Alice FletcherBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Sarah Blair-ReidBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
James BeesleyBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Balraj JohalBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Laurence H PearlGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0002-6910-1809
Robert NeelySchool of Chemistry, University of Birmingham, Birmingham, UK.
Nicholas H KeepDepartment of Biological Sciences, Institute for Structural and Molecular Biology, Birkbeck, University of London, London, UK.ORCID 0000-0002-5042-1837
Felicity Z WattsGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK.
Joanna R MorrisBirmingham Centre for Genome Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
University of Birmingham · GBUniversity of Sussex · GBBirkbeck, University of London · GB

Funding

Cancer Research UK 11978Cancer Research UK 14532Cancer Research UK 19062Cancer Research UK A11978Cancer Research UK C1206/A11978Cancer Research UK C302/A14532Cancer Research UK C8820/A19062
6 · The paper itself

Abstract

The opposing activities of 53BP1 and BRCA1 influence pathway choice in DNA double-strand-break repair. How BRCA1 counteracts the inhibitory effect of 53BP1 on DNA resection and homologous recombination is unknown. Here we identify the site of BRCA1-BARD1 required for priming ubiquitin transfer from E2∼ubiquitin and demonstrate that BRCA1-BARD1's ubiquitin ligase activity is required for repositioning 53BP1 on damaged chromatin. We confirm H2A ubiquitination by BRCA1-BARD1 and show that an H2A-ubiquitin fusion protein promotes DNA resection and repair in BARD1-deficient cells. BRCA1-BARD1's function in homologous recombination requires the chromatin remodeler SMARCAD1. SMARCAD1 binding to H2A-ubiquitin and optimal localization to sites of damage and activity in DNA repair requires its ubiquitin-binding CUE domains. SMARCAD1 is required for 53BP1 repositioning, and the need for SMARCAD1 in olaparib or camptothecin resistance is alleviated by 53BP1 loss. Thus, BRCA1-BARD1 ligase activity and subsequent SMARCAD1-dependent chromatin remodeling are critical regulators of DNA repair.

Indexed as

Gene Expression Regulation, NeoplasticRecombinational DNA RepairBinding SitesBRCA1 ProteinCamptothecinChromatinCloning, MolecularDNA Breaks, Double-StrandedDNA CleavageDNA HelicasesDNA, NeoplasmEscherichia coliGene ExpressionHeLa CellsHistonesHumansBARD1 protein, humanBRCA1 ProteinBRCA1 protein, humanCamptothecinChromatinDNA HelicasesDNA, NeoplasmHistonesolaparibPhthalazinesPiperazinesRecombinant ProteinsSMARCAD1 protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID27239795
PMCPMC6522385
OpenAlexW2382242955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.